SNRNP48 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.675380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.152000E-01
Normal-vs-Stage2
1.431790E-01
Normal-vs-Stage3
5.480200E-02
Normal-vs-Stage4
9.460600E-01
Stage1-vs-Stage2
7.661900E-02
Stage1-vs-Stage3
8.858200E-02
Stage1-vs-Stage4
9.601600E-01
Stage2-vs-Stage3
1.438590E-01
Stage2-vs-Stage4
1.179040E-01
Stage3-vs-Stage4
5.634000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.770360E-01
Normal-vs-AfricanAmerican
1.077030E-01
Normal-vs-Asian
2.995000E-01
Caucasian-vs-AfricanAmerican
8.499400E-01
Caucasian-vs-Asian
6.658600E-01
AfricanAmerican-vs-Asian
8.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.511600E-01
Normal-vs-Female
9.624400E-02
Male-vs-Female
2.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.442400E-01
Normal-vs-Age(41-60Yrs)
4.193800E-01
Normal-vs-Age(61-80Yrs)
6.576100E-02
Normal-vs-Age(81-100Yrs)
5.153400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.185800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.627600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.067400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.842100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.585000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.945200E-01
Normal-vs-Daily Drinker
3.062000E-02
Normal-vs-Weekly Drinker
9.539800E-02
Normal-vs-Occasional Drinker
3.588600E-01
Normal-vs-Social Drinker
1.009440E-01
Non Drinker-vs-Daily Drinker
4.349800E-02
Non Drinker-vs-Weekly Drinker
2.779000E-01
Non Drinker-vs-Occasional Drinker
8.151000E-01
Non Drinker-vs-Social Drinker
3.325000E-01
Daily Drinker-vs-Weekly Drinker
4.869600E-01
Daily Drinker-vs-Occasional Drinker
8.267800E-02
Daily Drinker-vs-Social Drinker
2.296600E-01
Weekly Drinker-vs-Occasional Drinker
3.438200E-01
Weekly Drinker-vs-Social Drinker
6.784400E-01
Occasional Drinker-vs-Social Drinker
5.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.722000E-01
Normal-vs-Grade 2
1.331600E-01
Normal-vs-Grade 3
1.261750E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.968600E-01
Grade 1-vs-Grade 3
6.868000E-01
Grade 1-vs-Grade 4
2.722000E-01
Grade 2-vs-Grade 3
6.689400E-01
Grade 2-vs-Grade 4
1.331600E-01
Grade 3-vs-Grade 4
1.261750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.278200E-02
Normal-vs-NonDiabetic
1.734570E-01
Diabetic-vs-NonDiabetic
4.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.665000E-01
Normal-vs-NoPancreatitis
1.420590E-01
Pancreatitis-vs-NoPancreatitis
5.381600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.829000E-01
Normal-vs-N1
1.387840E-01
N0-vs-N1
5.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.192200E-01
Normal-vs-TP53-NonMutant
4.627000E-01
TP53-Mutant-vs-TP53-NonMutant
8.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
